Capstone Capital Management Ltd increased its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 125.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 36,526 shares of the semiconductor company’s stock after purchasing an additional 20,306 shares during the quarter. Synopsys makes up 14.1% of Capstone Capital Management Ltd’s holdings, making the stock its 2nd largest position. Capstone Capital Management Ltd’s holdings in Synopsys were worth $14,482,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the company. China Universal Asset Management Co. Ltd. boosted its holdings in shares of Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock worth $6,957,000 after buying an additional 3,575 shares during the period. SeaTown Holdings Pte. Ltd. lifted its position in Synopsys by 55.9% during the fourth quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock worth $10,475,000 after acquiring an additional 8,000 shares during the last quarter. Norges Bank bought a new stake in shares of Synopsys during the fourth quarter worth approximately $730,197,000. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Synopsys by 11.3% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,369 shares of the semiconductor company’s stock worth $61,707,000 after acquiring an additional 13,320 shares during the period. Finally, Douglas Lane & Associates LLC grew its position in shares of Synopsys by 5,701.2% in the fourth quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock valued at $22,889,000 after purchasing an additional 47,890 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Price Performance
Synopsys stock opened at $434.50 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The stock has a market capitalization of $83.20 billion, a P/E ratio of 100.58, a price-to-earnings-growth ratio of 2.56 and a beta of 1.22. The stock has a fifty day moving average of $479.33 and a 200-day moving average of $460.96.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the company. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Needham & Company LLC reiterated a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Wells Fargo & Company lifted their target price on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Citigroup boosted their target price on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their price target for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $570.06.
Check Out Our Latest Stock Report on SNPS
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
